Today, June 9, NIH issued
Notice NOT-OD-20-123 which stated:
The NIH, AHRQ, and NIOSH understand that the emergency declaration related to Coronavirus Disease 2019 (COVID-19) will adversely affect the ability of many applicants to generate preliminary data in time for their grant applications submitted for the current due dates (for January 2021 Council beginning with applications submitted for the May 25, 2020 due date). However, with implementation of the President's Guidelines for Re-Opening America Again, NIH, AHRQ, and NIOSH anticipate that many investigators may be able to generate preliminary data for those applications before peer review. Therefore, this Notice provides an exception to the NIH/AHRQ/NIOSH policy for post-submission materials (NOT-OD-19-083).
For applications submitted for the January 2021 council (beginning with applications submitted for the May 25, 2020 due date for Fall 2020 review meetings), the NIH, AHRQ, and NIOSH will accept a one-page update with preliminary data as post-submission materials for applications submitted under all activity codes, ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application. One page of preliminary data will be accepted for single component applications or for each component of a multi-component application.
The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting. Because applications for emergency competitive revisions and urgent competitive revisions undergo expedited review, post-submission materials will not be accepted for those applications.
All other materials listed in NOT-OD-19-083 as acceptable post-submission materials will continue to be accepted if submitted 30 days before the study section meeting.
All inquires should be directed to:
Sally A. Amero, Ph.D.
NIH Review Policy Officer
ReviewPolicyOfficer@mail.nih.gov
Francis D. Chesley, Jr., M.D.
Agency for Healthcare Research and Quality
Telephone: 301-427-1521
Email:Francis.Chesley@ahrq.hhs.gov
Steve Dearwent, Ph.D.
Centers for Disease Control and Prevention
Telephone: 404-498-6382
Email:Sed7@cdc.gov
Michael Goldcamp, Ph.D.
Centers for Disease Control and Prevention
Telephone: 304-285-5951
Email: ehg8@cdc.gov